NeoGenomics, Inc. (NEO)
NCM · Common · CUSIP 64049M209
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for NEO and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
64049M209
Market Cap
Large Cap
Business: NeoGenomics, Inc. is a high-complexity CLI (certified clinical laboratory) that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology and molecular genetic testing. Headquartered in Fort Myers, FL, NeoGenomics has labs in Nashville, TN, Irvine, CA, Tampa, FL and Fort Myers, FL. NeoGenomics services the needs of pathologists, oncologists, other clinicians and hospitals throughout the United States.

Company Contact

CEO
Tony Zook
CFO
Jeffrey Sherman
Headquarters
9490 NeoGenomics Way,, Suite 9, Fort Myers, FL 33912
Phone
239-768-0600 · Toll-Free 866-776-5907
Fax
239-690-4237
Investor Relations
Kendra Sweeney · 239-768-0600 · kendra.sweeney@neogenomics.com
SEC EDGAR Filings
View filings »